|
WO2007135571A2
|
|
Blood group antigens of different types for diagnostic and therapeutic applications
|
|
CA2559110A1
|
|
Endothelial progenitor cells and methods of use thereof
|
|
BRPI0406242A
|
|
donor-specific cross-matching processes
|
|
AU2003241107A1
|
|
Method of isolating an endothelial cell and method of donor specific crossmatching
|
|
CA2483474A1
|
|
Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
|
|
CA2483473A1
|
|
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
AU2002321760B2
|
|
Blood group antigen fusion polypeptides and methods of use thereof
|
|
WO0113947A1
|
|
Reduction of the immunogenicity of non-human grafts
|
|
EP1700868A2
|
|
A method for removing an antibody from blood or plasma
|
